India's Pharmaceutical Exports

Country Profile

Mauritania

Mauritania is an emerging destination for Indian pharmaceutical exports — $12.2M in FY 2025–26, with 3.4× growth over the past decade. Medicines accounts for 77% of shipments, with vaccines contributing $2.62M. The compound annual growth rate since FY2015 stands at 11.7%.

🇲🇷 $12.2M · 3.4× growth since FY2015 · 11.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$12.2M
Exports FY2025–26 DGCIS
3.4×
Growth FY2015→2026
11.7%
CAGR FY2015→2026
77%
Medicines Share
4
Product Categories Supplied
Mauritania is an emerging destination for Indian pharmaceutical exports — $12.2M in FY 2025–26, with 3.4× growth over the past decade. Medicines accounts for 77% of shipments, with vaccines contributing $2.62M. The compound annual growth rate since FY2015 stands at 11.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $9.41M (77.0%) Vaccines $2.62M (21.4%) Surgical & Hospital Supplies $183K (1.5%) Traditional & Herbal $17K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Mauritania in the RBI overseas direct investment dataset (2011–2026).